336 related articles for article (PubMed ID: 10021861)
21. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
[TBL] [Abstract][Full Text] [Related]
22. [High dosage stain protects heart and brain from recurrence].
MMW Fortschr Med; 2008 Nov; 150(48):118-9. PubMed ID: 19125516
[No Abstract] [Full Text] [Related]
23. [Prevention of cardiovascular diseases: Value of CSE inhibitors in the management of lipid metabolism disorders].
Z Kardiol; 1998 Apr; 87(4 Suppl Stellenwer):1-4. PubMed ID: 9618894
[No Abstract] [Full Text] [Related]
24. [Considerable LDL lowering is advantageous].
MMW Fortschr Med; 2005 Sep; 147(35-36):9. PubMed ID: 16180563
[No Abstract] [Full Text] [Related]
25. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
[TBL] [Abstract][Full Text] [Related]
26. [Sequelae of the CARDS Study. LDL of 110 mg/dl still too high?].
Klose G
MMW Fortschr Med; 2004 Jun; 146(26):14. PubMed ID: 15529683
[No Abstract] [Full Text] [Related]
27. [Coronary heart disease patient reaches LDL level of 100 mg/dl with atorvastatin: how do you continue treatment next year?].
Weizel A; Sawicki PT
MMW Fortschr Med; 2004 Dec; 146(51-52):14, 16. PubMed ID: 15675236
[No Abstract] [Full Text] [Related]
28. Effects of atorvastatin versus probucol on low-density lipoprotein subtype distribution and renal function in hyperlipidemic patients with nondiabetic nephropathy.
Yasuda G; Ando D; Hirawa N; Umemura S
Ren Fail; 2010 Jul; 32(6):680-6. PubMed ID: 20540635
[TBL] [Abstract][Full Text] [Related]
29. Atorvastatin.
Hyatt PJ
Br J Hosp Med; 1997 Oct 1-14; 58(7):333-6. PubMed ID: 9509055
[No Abstract] [Full Text] [Related]
30. Statin therapy works for patients who have type 2 diabetes.
Korber KE
JAAPA; 2008 Oct; 21(10):58, 60. PubMed ID: 19024640
[No Abstract] [Full Text] [Related]
31. [Following the ASCOT Study. A statin for every hypertensive patient?].
MMW Fortschr Med; 2003 Apr; 145(16):8. PubMed ID: 14606391
[No Abstract] [Full Text] [Related]
32. [AVERT study (Atorvastatin Versus Revascularization Treatment). Clinical advantage of aggressive lipid lowering].
Z Kardiol; 1999 Mar; 88(3 Suppl):1-4. PubMed ID: 10330699
[No Abstract] [Full Text] [Related]
33. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
LaRosa JC; Grundy SM; Kastelein JJ; Kostis JB; Greten H;
Am J Cardiol; 2007 Sep; 100(5):747-52. PubMed ID: 17719314
[TBL] [Abstract][Full Text] [Related]
34. Ezetimibe is effective when added to maximally tolerated lipid lowering therapy in patients with HIV.
Bennett MT; Johns KW; Bondy GP
Lipids Health Dis; 2007 Jun; 6():15. PubMed ID: 17565701
[TBL] [Abstract][Full Text] [Related]
35. [Target values are more often attainable. Almost doubly so many patients with values under 100mg/dl].
MMW Fortschr Med; 2004 Oct; 146(44):57. PubMed ID: 15566254
[No Abstract] [Full Text] [Related]
36. Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia.
Sakabe K; Fukuda N; Wakayama K; Nada T; Shinohara H; Tamura Y
Am J Cardiol; 2004 Aug; 94(4):497-500. PubMed ID: 15325939
[TBL] [Abstract][Full Text] [Related]
37. Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
Robinson JG; Davidson MH
Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):461-76. PubMed ID: 16918265
[TBL] [Abstract][Full Text] [Related]
38. A statin for a patient with hyperlipidemia and hepatitis C?
Nash DT
Postgrad Med; 2004 May; 115(5):86. PubMed ID: 15171081
[No Abstract] [Full Text] [Related]
39. [Fluvastatin in a comparative study. Are there substance-specific differences between various CSE-inhibitors?].
Internist (Berl); 1999 Mar; 40(3 Suppl Gibt Es):1-4. PubMed ID: 10192028
[No Abstract] [Full Text] [Related]
40. Indications and outcome of treatment of hyperlipidemia in pediatric allograft recipients.
Silverstein DM
Pediatr Transplant; 2003 Feb; 7(1):7-10. PubMed ID: 12581321
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
